Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/Benazepril for LVH in High Risk Hypertension
NCT00139555Phase 4Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Primary completion
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amlodipine besylate + benazepril hydrochloride in hypertension (HTN) and left ventricular hypertrophy (LVH), sponsored by Novartis. Primary endpoint: Change from baseline in left ventricular mass index at 52 weeks. Started Jul 2004; status: completed.
02
Drugs
amlodipine besylate + benazepril hydrochloride
03
Conditions
hypertension (HTN)left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on NCT00139555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139555.